ReachRxResearch
Home
Research
Sign Up
Attention-Deficit/Hyperactivity Disorder and Late-Life Cognitive Impairment
Back to Research Hub
  1. Home
  2. Research Hub
  3. Attention-Deficit/Hyperactivity Disorder…

Attention-Deficit/Hyperactivity Disorder and Late-Life Cognitive Impairment

JAMA Psychiatry·October 7
PsychiatryPractice changingAttention-Deficit/Hyperactivity DisorderDementiaMild Cognitive ImpairmentRetrospective Cohort StudyOlder Adult

Summary

View source

What was studied

This retrospective cohort study used the US All of Us Research Program (n=187,341 adults ≥50 years, mean follow-up 10.26 years) to examine whether EHR-documented ADHD diagnosis and ADHD polygenic risk score (PRS) were each independently associated with incident mild cognitive impairment (MCI) or dementia, and whether comorbid ADHD worsened outcomes among those who developed cognitive impairment.

Key findings

ADHD was associated with a >4-fold higher hazard of MCI or dementia (adjusted HR 4.60; 95% CI 3.99–5.29); high ADHD PRS (vs. low) added a 35% higher hazard (HR 1.35; 95% CI 1.25–1.46). Among those who developed cognitive impairment, comorbid ADHD was linked to ~2-fold higher odds of suboptimal mental health (OR 1.69), quality of life (OR 1.66), and social satisfaction (OR 2.39), plus 20% more total healthcare utilization.

Study limitations

Reverse causation cannot be excluded given the long dementia prodrome — lagged analyses showed the ADHD–cognitive impairment association became non-significant at 9-year minimum intervals. EHR-based diagnosis is subject to underascertainment and differential healthcare access bias. The ADHD PRS was derived predominantly from European-ancestry GWAS data, limiting applicability to other ancestry groups.

Clinical implications

Adults with ADHD appear to carry a substantially elevated risk of late-life cognitive impairment, supported by both clinical and genetic evidence; clinicians should consider proactive cognitive monitoring in older patients with ADHD. Those who develop MCI or dementia alongside ADHD need integrated mental health support and careful care coordination, given their greater symptom burden and healthcare use.

Caveats

  • Reverse causation is a material concern: the association attenuated progressively with longer required intervals between ADHD diagnosis and cognitive impairment onset, becoming non-significant at 9 years, consistent with possible prodromal misattribution of early cognitive symptoms as ADHD
  • The ADHD prevalence in this cohort (1.6%) is lower than general population estimates, and the majority of diagnosed ADHD participants were women and had higher educational attainment — both atypical for ADHD — suggesting potential selection bias in this volunteer research cohort. Findings may not generalize to broader clinical populations with ADHD
  • The study could not evaluate whether ADHD pharmacotherapy modifies cognitive impairment risk, leaving a key clinical question unanswered

Related Questions

Explore related topics

What is the risk of dementia in older adults diagnosed with ADHD?Does ADHD treatment with stimulants reduce the risk of cognitive decline in older adults?How should clinicians monitor cognitive function in aging patients with ADHD?

Publication Details

Year
2026
Journal
JAMA Psychiatry
Sample Size
n=187,341
Source
View article
Keep scrolling
More content below.
Up Next